Business
– Results from Final Phase III Study of in Patients with Major Depression Associated with Bipolar I Disorder failed to show that it was...
Hi, what are you looking for?
– Results from Final Phase III Study of in Patients with Major Depression Associated with Bipolar I Disorder failed to show that it was...
– This approval provides the regulatory framework for the commercialization of Lonquex in all 28 EU countries. – Illustration Teva Pharmaceutical Industries Ltd...
– Products developed by the Weizmann Institute have $20 billion in annual sales. – – / By Gali Weinreb / The campus of the...
– Dr. Phillip Frost, the chairman of both Opko and Prolor, has the right to vote on the merger of the two companies on...
– – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Switzerland’s Lonza Group AG (SXW: LONN) announced today that, following a strategic review...
– Jeremy Levin – / By David Frank / This week revealed the 2012 salary for the CEO of Teva Pharmaceuticals (NASDAQ: TEVA). Teva...
– Altogether, the partial list of tax breaks released by the Ministry of Finance shows that large corporations received NIS 16.5 billion (about $4.7...
– / By Alan Gallindoss/ On June 12th Jewish Business News reported that Teva had settled a major lawsuit brought against it by Pfizer...
– Six dual-listed companies with an aggregate market cap of NIS 6.5 billion delisted from the TASE in 2010-12. – – / By Shiri...
– Apoptosis – /By Alan Gallindoss / Apotex has developed new molecular-level imaging technology to detect diseases within human cells, and potentially help therapeutically...